Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

42%

5 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

4(50.0%)

N/A

1(12.5%)

Phase 1

1(12.5%)

Phase 2

1(12.5%)

Phase 3

1(12.5%)

8Total

Phase 4(4)

N/A(1)

Phase 1(1)

Phase 2(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT03331718Phase 3Completed

PoLyglycolic Acid Felt reiNforcEmenT of the PancreaticoJejunostomy (PLANET-PJ Trial)

Role: collaborator

NCT03778775Unknown

Transient Elastography (FibroTouch) for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis (Pan-CHESS1801)

Role: collaborator

NCT02455830Unknown

Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy

Role: collaborator

NCT02256618Phase 1Completed

Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy

Role: collaborator

NCT02037776Phase 4Completed

The Efficacy and Safety Study of Rikkunshito in Patients With Functional Dyspepsia

Role: lead

NCT01760967Phase 4Completed

Dexmedetomidine for Sepsis in ICU Randomized Evaluation Trial

Role: collaborator

NCT00599560Not ApplicableCompleted

Vasopressin and V2 Receptor in Meniere's Disease

Role: collaborator

NCT00162955Phase 4Completed

Prevention of CHOP-induced Chronic Cardiotoxicity

Role: lead

NCT01120002Phase 2Unknown

Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

Role: lead

NCT00854919Phase 4Completed

Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder

Role: lead

NCT00219427Completed

Retina Projection System Trials for Low Vision People

Role: lead

NCT00244400Completed

Examine the Possible Association of Hepatic CYP3A Activity and the Susceptibility to Femur Head Necrosis

Role: lead

All 12 trials loaded